vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and FONAR CORP (FONR). Click either name above to swap in a different company.
BCB BANCORP INC is the larger business by last-quarter revenue ($26.2M vs $25.5M, roughly 1.0× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs -49.7%, a 57.7% gap on every dollar of revenue. On growth, BCB BANCORP INC posted the faster year-over-year revenue change (13.1% vs 2.4%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $-227.0K). Over the past eight quarters, BCB BANCORP INC's revenue compounded faster (1.8% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
BCBP vs FONR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.2M | $25.5M |
| Net Profit | $-12.0M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | -71.9% | 13.5% |
| Net Margin | -49.7% | 8.0% |
| Revenue YoY | 13.1% | 2.4% |
| Net Profit YoY | -467.6% | 4.7% |
| EPS (diluted) | $-0.73 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | $25.5M | ||
| Q3 25 | $26.5M | $26.0M | ||
| Q2 25 | $25.2M | $27.3M | ||
| Q1 25 | $23.8M | $27.2M | ||
| Q4 24 | $23.1M | $24.9M | ||
| Q3 24 | $26.2M | $25.0M | ||
| Q2 24 | $20.4M | $25.9M | ||
| Q1 24 | $25.3M | $25.7M |
| Q4 25 | $-12.0M | $2.1M | ||
| Q3 25 | $4.3M | $2.3M | ||
| Q2 25 | $3.6M | $729.3K | ||
| Q1 25 | $-8.3M | $2.5M | ||
| Q4 24 | $3.3M | $2.0M | ||
| Q3 24 | $6.7M | $3.1M | ||
| Q2 24 | $2.8M | $830.4K | ||
| Q1 24 | $5.9M | $1.9M |
| Q4 25 | -71.9% | 13.5% | ||
| Q3 25 | 21.9% | 14.1% | ||
| Q2 25 | 19.9% | 5.3% | ||
| Q1 25 | -49.2% | 15.2% | ||
| Q4 24 | 19.9% | 11.9% | ||
| Q3 24 | 35.7% | 21.0% | ||
| Q2 24 | 19.5% | 7.4% | ||
| Q1 24 | 33.0% | 16.8% |
| Q4 25 | -49.7% | 8.0% | ||
| Q3 25 | 16.1% | 8.7% | ||
| Q2 25 | 14.2% | 2.7% | ||
| Q1 25 | -35.0% | 9.2% | ||
| Q4 24 | 14.1% | 7.9% | ||
| Q3 24 | 25.5% | 12.6% | ||
| Q2 24 | 13.8% | 3.2% | ||
| Q1 24 | 23.2% | 7.3% |
| Q4 25 | $-0.73 | — | ||
| Q3 25 | $0.22 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $-0.51 | — | ||
| Q4 24 | $0.17 | — | ||
| Q3 24 | $0.36 | — | ||
| Q2 24 | $0.14 | — | ||
| Q1 24 | $0.32 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $121.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $304.3M | $176.9M |
| Total Assets | $3.3B | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $121.0K | ||
| Q3 25 | — | $122.0K | ||
| Q2 25 | — | $56.5M | ||
| Q1 25 | — | $123.0K | ||
| Q4 24 | — | $121.0K | ||
| Q3 24 | — | $136.0K | ||
| Q2 24 | — | $56.5M | ||
| Q1 24 | — | $134.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
| Q4 25 | $304.3M | $176.9M | ||
| Q3 25 | $318.5M | $174.9M | ||
| Q2 25 | $315.7M | $172.6M | ||
| Q1 25 | $314.7M | $171.9M | ||
| Q4 24 | $323.9M | $169.8M | ||
| Q3 24 | $328.1M | $168.7M | ||
| Q2 24 | $320.7M | $166.0M | ||
| Q1 24 | $320.1M | $165.8M |
| Q4 25 | $3.3B | $217.2M | ||
| Q3 25 | $3.4B | $218.4M | ||
| Q2 25 | $3.4B | $216.9M | ||
| Q1 25 | $3.5B | $214.9M | ||
| Q4 24 | $3.6B | $208.0M | ||
| Q3 24 | $3.6B | $212.3M | ||
| Q2 24 | $3.8B | $214.2M | ||
| Q1 24 | $3.8B | $209.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $171.0K |
| Free Cash FlowOCF − Capex | $34.9M | $-227.0K |
| FCF MarginFCF / Revenue | 133.3% | -0.9% |
| Capex IntensityCapex / Revenue | 4.0% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | $171.0K | ||
| Q3 25 | $8.7M | $1.7M | ||
| Q2 25 | $10.3M | $4.2M | ||
| Q1 25 | $5.0M | $3.1M | ||
| Q4 24 | $67.7M | $2.2M | ||
| Q3 24 | $43.5M | $1.7M | ||
| Q2 24 | $8.1M | $4.6M | ||
| Q1 24 | $8.3M | $2.8M |
| Q4 25 | $34.9M | $-227.0K | ||
| Q3 25 | $8.5M | $-177.0K | ||
| Q2 25 | $10.2M | $3.6M | ||
| Q1 25 | $4.7M | $2.6M | ||
| Q4 24 | $66.5M | $1.5M | ||
| Q3 24 | $43.4M | $-148.0K | ||
| Q2 24 | $8.1M | $4.2M | ||
| Q1 24 | $8.1M | $2.6M |
| Q4 25 | 133.3% | -0.9% | ||
| Q3 25 | 32.0% | -0.7% | ||
| Q2 25 | 40.4% | 13.1% | ||
| Q1 25 | 19.8% | 9.4% | ||
| Q4 24 | 287.5% | 6.0% | ||
| Q3 24 | 166.0% | -0.6% | ||
| Q2 24 | 39.6% | 16.1% | ||
| Q1 24 | 32.3% | 10.2% |
| Q4 25 | 4.0% | 1.6% | ||
| Q3 25 | 1.1% | 7.2% | ||
| Q2 25 | 0.6% | 2.4% | ||
| Q1 25 | 1.2% | 2.2% | ||
| Q4 24 | 5.3% | 3.0% | ||
| Q3 24 | 0.3% | 7.2% | ||
| Q2 24 | 0.2% | 1.6% | ||
| Q1 24 | 0.6% | 0.7% |
| Q4 25 | — | 0.08× | ||
| Q3 25 | 2.05× | 0.75× | ||
| Q2 25 | 2.90× | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | 20.70× | 1.14× | ||
| Q3 24 | 6.53× | 0.53× | ||
| Q2 24 | 2.88× | 5.54× | ||
| Q1 24 | 1.41× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCBP
Segment breakdown not available.
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
